The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Rotenone-induced Impairment of Mitochondrial Electron Transport Chain Confers a Selective Priming Signal for NLRP3 Inflammasome Activation
Open accessAbstract
Mitochondrial dysfunction is considered crucial for NLRP3 inflammasome activation partly through its release of mitochondrial toxic products, such as mitochondrial reactive oxygen species (mROS) 2 2The abbreviations used are: mROSmitochondrial reactive oxygen speciesmtDNAmitochondrial DNABMDMbone marrow-derived macrophageETCelectron transport chainMPTmitochondrial permeability transitionCCCPcarbonyl cyanide m-chlorophenylhydrazoneNACN-acetyl-l-cysteineZ-benzyloxycarbonyl-fmkfluoromethyl ketone. and mitochondrial DNA (mtDNA). Although previous studies have shown that classical NLRP3-activating stimulations lead to mROS generation and mtDNA release, it remains poorly understood whether and how mitochondrial damage-derived factors may contribute to NLRP3 inflammasome activation. Here, we demonstrate that impairment of the mitochondrial electron transport chain by rotenone primes NLRP3 inflammasome activation only upon costimulation with ATP and not with nigericin or alum. Rotenone-induced priming of NLRP3 in the presence of ATP triggered the formation of specklike NLRP3 or ASC aggregates and the association of NLRP3 with ASC, resulting in NLRP3-dependent caspase-1 activation. Mechanistically, rotenone confers a priming signal for NLRP3 inflammasome activation only in the context of aberrant high-grade, but not low-grade, mROS production and mitochondrial hyperpolarization. By contrast, rotenone/ATP-mediated mtDNA release and mitochondrial depolarization are likely to be merely an indication of mitochondrial damage rather than triggering factors for NLRP3 inflammasome activation. Our results provide a molecular insight into the selective contribution made by mitochondrial dysfunction to the NLRP3 inflammasome pathway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several studies have shown that inhibition of mitochondrial complex I by rotenone or of complex III by antimycin A induces robust ROS production by mitochondria, which is sufficient to drive NLRP3 inflammasome activation.39, 40”
From Trimethylamine‐N‐Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3‐SOD2‐mtROS Signaling Pathway (2017) · cites this paper as [40]
Citations
Cites
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Nakahira, K., Haspel, J. A., Rathinam, V. A. K., Lee, S.-J., Dolinay, T., Lam, H. C., Englert, J. A., Rabinovitch, M., Cernadas, M., Kim, H. P., et al. (2011) · Nature Immunology · doi:10.1038/ni.1980 · Cited by 3,049
Activation and regulation of the inflammasomes
Latz, E., Xiao, T. S., & Stutz, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3452 · Cited by 2,884
Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis
Shimada, K., Crother, T. R., Karlin, J., Dagvadorj, J., Chiba, N., Chen, S., Ramanujan, V. K., Wolf, A. J., Vergnes, L., Ojcius, D. M., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.009 · Cited by 2,282
Muñoz-Planillo, R., Kuffa, P., Martínez-Colón, G. J., Smith, B. L., Rajendiran, T. M., & Núñez, G. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.016 · Cited by 2,167
AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA
Fernandes-Alnemri, T., Yu, J.-W., Datta, P., Wu, J., & Alnemri, E. S. (2009) · Nature · doi:10.1038/nature07710 · Cited by 1,831
Self-citationAgostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
Li, N., Ragheb, K., Lawler, G., Sturgis, J., Rajwa, B. P., Melendez, J. A., & Robinson, J. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210432200 · Cited by 1,465
Mitochondrial Cardiolipin Is Required for Nlrp3 Inflammasome Activation
Iyer, S. S., He, Q., Janczy, J. R., Elliott, E. I., Zhong, Z., Olivier, A. K., Sadler, J. J., Knepper-Adrian, V., Han, R., Qiao, L., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.001 · Cited by 968
Flagged first, then by citations
Cited by
Sorted by citations
Inflammasome signalling in brain function and neurodegenerative disease
Heneka, M. T., McManus, R. M., & Latz, E. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0055-7 · Cited by 836
Hypoxia, oxidative stress and inflammation
McGarry, T., Biniecka, M., Veale, D. J., & Fearon, U. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.03.042 · Cited by 620
Chen, M., Zhu, X., Ran, L., Lang, H., Yi, L., & Mi, M. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006347 · Cited by 600
K + Efflux-Independent NLRP3 Inflammasome Activation by Small Molecules Targeting Mitochondria
Groß, C. J., Mishra, R., Schneider, K. S., Médard, G., Wettmarshausen, J., Dittlein, D., Shi, H., Gorka, O., Koenig, P.-A., Fromm, S., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.08.010 · Cited by 550
Mitochondrial ROS promote macrophage pyroptosis by inducing GSDMD oxidation
Wang, Y., Shi, P., Chen, Q., Huang, Z., Zou, D., Zhang, J., Gao, X., & Lin, Z. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz020 · Cited by 365
Molecular mechanisms of environmental exposures and human disease
Wu, H., Eckhardt, C. M., & Baccarelli, A. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-022-00569-3 · Cited by 296
Targeting the Microglial NLRP3 Inflammasome and Its Role in Parkinson's Disease
Haque, M. E., Akther, M., Jakaria, M., Kim, I., Azam, S., & Choi, D. (2019) · Movement Disorders · doi:10.1002/mds.27874 · Cited by 251
Mitochondria and Critical Illness
Supinski, G. S., Schroder, E. A., & Callahan, L. A. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.08.2182 · Cited by 212
Mitochondrial dysfunction as a trigger of innate immune responses and inflammation
West, A. P. (2017) · Toxicology · doi:10.1016/j.tox.2017.07.016 · Cited by 206
The NLRP3 Inflammasome: Metabolic Regulation and Contribution to Inflammaging
Meyers, A. K., & Zhu, X. (2020) · Cells · doi:10.3390/cells9081808 · Cited by 207
Wu, A., Zhou, X., Qiao, G., Yu, L., Tang, Y., Yan, L., Qiu, W., Pan, R., Yu, C., Law, B. Y. K., et al. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101202 · Cited by 196
Jang, J., Park, S., Jin Hur, H., Cho, H.-J., Hwang, I., Pyo Kang, Y., Im, I., Lee, H., Lee, E., Yang, W., et al. (2016) · Nature Communications · doi:10.1038/ncomms13129 · Cited by 166
Self-citationHe, Z., Zou, S., Li, M., Liao, F.-L., Wu, X., Sun, H., Zhao, X., Hu, Y., Li, D., Xu, X., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101364 · Cited by 170
Advances in the understanding of mitochondrial DNA as a pathogenic factor in inflammatory diseases
Boyapati, R. K., Tamborska, A., Dorward, D. A., & Ho, G. (2017) · F1000Research · doi:10.12688/f1000research.10397.1 · Cited by 170
Mitochondrial DNA as an inflammatory mediator in cardiovascular diseases
Nakayama, H., & Otsu, K. (2018) · Biochemical Journal · doi:10.1042/bcj20170714 · Cited by 160
Mohanty, A., Tiwari-Pandey, R., & Pandey, N. R. (2019) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-019-00507-9 · Cited by 164
NLRP3 inflammasome: a promising target in ischemic stroke
Gao, L., Dong, Q., Song, Z., Shen, F., Shi, J., & Li, Y. (2016) · Inflammation Research · doi:10.1007/s00011-016-0981-7 · Cited by 150
Stringer, J. M., Alesi, L. R., Winship, A., & Hutt, K. J. (2023) · Human Reproduction Update · doi:10.1093/humupd/dmad005 · Cited by 157
NLRP3 inflammasome in neurodegenerative disease
Anderson, F. L., Biggs, K. E., Rankin, B. E., & Havrda, M. C. (2022) · Translational research · doi:10.1016/j.trsl.2022.08.006 · Cited by 154
Mitochondria as a centrally positioned hub in the innate immune response
Sandhir, R., Halder, A., & Sunkaria, A. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.10.020 · Cited by 135
Wang, H., Yang, F., Zhang, S., Xin, R., & Sun, Y. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00213-7 · Cited by 135
Traba, J., Geiger, S. S., Osei, M. A., Han, K., Ra, O. H., Siegel, R. M., Gius, D. R., & Sack, M. N. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.791715 · Cited by 120
Stressing out the mitochondria: Mechanistic insights into NLRP3 inflammasome activation
Yabal, M., Calleja, D. J., Simpson, D. S., & Lawlor, K. E. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0318-124r · Cited by 110
The mitochondrial dynamics in cancer and immune-surveillance
Simula, L., Nazio, F., & Campello, S. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.06.007 · Cited by 106
Han, Y., Liu, X., Jin, M., Sun, H., & Kwon, T. (2023) · Inflammation Research · doi:10.1007/s00011-023-01790-4 · Cited by 114
Inflammasomes in neurological disorders — mechanisms and therapeutic potential
Ravichandran, K. A., & Heneka, M. T. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-023-00915-x · Cited by 112
Mitochondrial Control of Innate Immunity and Inflammation
Jin, H. S., Suh, H., Kim, S., & Jo, E. (2017) · Immune Network · doi:10.4110/in.2017.17.2.77 · Cited by 101
Singh, K., Chen, Y., Hassanzadeh, S., Han, K., Judy, J., Seifuddin, F., Tunc, I., Sack, M. N., & Pirooznia, M. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.599261 · Cited by 99
Unraveling the Link Between Mitochondrial Dynamics and Neuroinflammation
de Oliveira, L. G., Angelo, Y. D. S., Iglesias, A. H., & Peron, J. P. S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.624919 · Cited by 100
Harrington, J. S., Choi, A. M. K., & Nakahira, K. (2017) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000427 · Cited by 87
Natural compounds flavonoids as modulators of inflammasomes in chronic diseases
Owona, B. A., Abia, W. A., & Moundipa, P. F. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106498 · Cited by 88
Metabolic Reprogramming in Mitochondria of Myeloid Cells
Zuo, H., & Wan, Y. (2019) · Cells · doi:10.3390/cells9010005 · Cited by 83
Neuropathological Mechanisms Associated with Pesticides in Alzheimer’s Disease
Tang, B. L. (2020) · Toxics · doi:10.3390/toxics8020021 · Cited by 84
Modulation of Autophagy for Controlling Immunity
Jang, Y. J., Kim, J. H., & Byun, S. (2019) · Cells · doi:10.3390/cells8020138 · Cited by 74
Lawana, V., Singh, N., Sarkar, S., Charli, A., Jin, H., Anantharam, V., Kanthasamy, A. G., & Kanthasamy, A. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9746-5 · Cited by 73
Bellezza, I., Grottelli, S., Costanzi, E., Scarpelli, P. T., Pigna, E., Morozzi, G., Mezzasoma, L., Peirce, M. J., Moresi, V., Adamo, S., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0502-x · Cited by 73
Mitochondrial DNA signals driving immune responses: Why, How, Where?
Giordano, L., Ware, S. A., Lagranha, C. J., & Kaufman, B. A. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02042-0 · Cited by 82
Zhou, S., Xue, J., Shan, J., Hong, Y., Zhu, W., Nie, Z., Zhang, Y., Ji, N., Luo, X., Zhang, T., et al. (2022) · Nutrients · doi:10.3390/nu14163338 · Cited by 74
Soraci, L., Gambuzza, M. E., Biscetti, L., Laganà, P., Russo, C. L., Buda, A., Barresi, G., Corsonello, A., Lattanzio, F., Lorello, G., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11491-3 · Cited by 76
Armentero, M., Cerri, S., & Blandini, F. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00232 · Cited by 75
Dong, X., He, Y., Feng, Y., Zhao, Y., Cheng, J. S., Xiao, J., Yu, W., Zhao, J., Sai, Y., Dan, G., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.312 · Cited by 63
Son, S., Hwang, I., Han, S. H., Shin, J., Shin, O. S., & Yu, J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.806307 · Cited by 64
Self-citationRedox-signals and macrophage biology
Weigert, A., von Knethen, A., Fuhrmann, D. C., Dehne, N., & Brüne, B. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.01.003 · Cited by 60
Circulating Mitochondrial DNA as Predictor of Mortality in Critically Ill Patients
Harrington, J. S., Huh, J. W., Schenck, E. J., Nakahira, K., Siempos, I. Ι., & Choi, A. M. K. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.07.014 · Cited by 56
Martinez, E. M., Young, A. L., Patankar, Y. R., Berwin, B. L., Wang, L., von Herrmann, K. M., Weier, J. M., & Havrda, M. C. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx117 · Cited by 59
Parkinson's disease: connecting mitochondria to inflammasomes
Lawrence, G. M. E. P., Holley, C. L., & Schroder, K. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.09.010 · Cited by 57
Mitochondrial fidelity and metabolic agility control immune cell fate and function
Sack, M. N. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120845 · Cited by 54
Shi, Y., Wang, Y., Jiang, H., Sun, X., Xu, H., Xue, W., Yan, W., Xiao, G., Song, Z., & Zhou, F. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03984-2 · Cited by 55
NLRP3 inflammasomes: A potential target to improve mitochondrial biogenesis in Parkinson's disease
Khot, M., Sood, A., Tryphena, K. P., Khan, S. S., Srivastava, S., Singh, S. B., & Khatri, D. K. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175300 · Cited by 56
Kanthasamy, A., Jin, H., Charli, A., Anantharam, V., & Kanthasamy, A. G. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.01.001 · Cited by 57
Impact of pharmacological agents on mitochondrial function: a growing opportunity?
Stoker, M. L., Newport, E., Hulit, J., West, A. P., & Morten, K. (2019) · Biochemical Society Transactions · doi:10.1042/bst20190280 · Cited by 51
NLRP inflammasome as a key role player in the pathogenesis of environmental toxicants
Moloudizargari, M., Moradkhani, F., Asghari, N., Fallah, M., Asghari, M. H., Moghadamnia, A. A., & Abdollahi, M. R. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116585 · Cited by 53
Li, S., Liang, F., Kwan, K., Tang, Y., Wang, X., Tang, Y., Li, J., Yang, H., Chavan, S. S., Wang, H., et al. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0006-9 · Cited by 50
Ojeda, D. S., Grasso, D., Urquiza, J., Till, A., Vaccaro, M. I., & Quarleri, J. F. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02633 · Cited by 50
Anderson, F. L., Coffey, M., Berwin, B. L., & Havrda, M. C. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy219 · Cited by 48
Si, X., Fang, Y., Li, L., Gu, L., Yin, X., Jun-Tian, Yan, Y., Pu, J., & Zhang, B. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113525 · Cited by 46
Yan, W., Xiao, G., Xu, H., Sun, X., Shi, Y., Wang, F., Kang, J., Peng, J., & Zhou, F. (2023) · FEBS Journal · doi:10.1111/febs.16769 · Cited by 45
Cheng, H., Ji, Z., Wang, Y., Li, S., Tang, T., Wang, F., Peng, C., Wu, X., CHENG, Y. N., Liu, Z., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01701-1 · Cited by 43
The role of mitochondrial dynamics in disease
Wang, Y., Dai, X., Li, H., Jiang, H., Zhou, J.-F., Zhang, S., Guo, J., Shen, L., Yang, H., Lin, J. M., et al. (2023) · MedComm · doi:10.1002/mco2.462 · Cited by 41
Mitochondrial DNA: A Key Regulator of Anti-Microbial Innate Immunity
Kausar, S., Yang, L., Abbas, M. N., Hu, X., Zhao, Y., Zhu, Y., & Cui, H. (2020) · Genes · doi:10.3390/genes11010086 · Cited by 40
mtDNA in the Pathogenesis of Cardiovascular Diseases
Wang, L., Zhang, Q., Yuan, K., & Yuan, J. (2021) · Disease Markers · doi:10.1155/2021/7157109 · Cited by 40
Microglia in Neurodegenerative Events—An Initiator or a Significant Other?
Harry, G. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115818 · Cited by 37
Inflammasome activation in neurodegenerative diseases
Ravichandran, K. A., & Heneka, M. T. (2021) · Essays in Biochemistry · doi:10.1042/ebc20210021 · Cited by 37
Vastegani, S. M., Khoshnam, S. E., Mansouri, E., Hajipour, S., Ghafouri, S., Bakhtiari, N., Sarkaki, A., & Farbood, Y. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114100 · Cited by 34
Immunomodulatory/anti-inflammatory effect of ZOE-based dental materials
Lee, J., Lee, H., Kim, H., Yu, J., Kim, K.-N., & Kim, K.-M. (2016) · Dental Materials · doi:10.1016/j.dental.2016.09.012 · Cited by 31
Self-citationValenzuela-Arzeta, I. E., Soto-Rojas, L. O., Flores-Martinez, Y. M., Delgado-Minjares, K. M., Gatica-García, B., Mascotte-Cruz, J. U., Nava, P., Aparicio‐Trejo, O. E., Reyes-Corona, D., Martínez-Dávila, I. A., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054628 · Cited by 29
Xue, T., Chen, W., Liu, Z., Feng, T., Li, H., Ding, S., Chen, Y., Zhang, Y., Tang, X., & Geng, D. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2537-4 · Cited by 29
Weatherly, L. M., Shane, H. L., Friend, S. A., Lukomska, E., Baur, R., & Anderson, S. E. (2020) · Toxicological Sciences · doi:10.1093/toxsci/kfaa056 · Cited by 27
A flow-cytometry-based protocol for detection of mitochondrial ROS production under hypoxia
Yang, Y., Zhang, G., Yang, T., Gan, J., Xu, L., & Yang, H. (2021) · STAR Protocols · doi:10.1016/j.xpro.2021.100466 · Cited by 27
Pradhan, P., Vijayan, V., Cirksena, K., Buettner, F. F. R., Igarashi, K., Motterlini, R., Foresti, R., & Immenschuh, S. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102265 · Cited by 28
Mun, Y., Kim, J., Choi, Y., & Lee, B. (2025) · Antioxidants · doi:10.3390/antiox14111276 · Cited by 28
Wang, L., Zhu, L.-R., Duan, C., Li, L., & Chen, G. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11035 · Cited by 21
Wang, X., Li, H., Mu, H., Zhang, S., Li, Y., Han, X., Zhang, L., & Xiang, W. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115186 · Cited by 19
Immune cell metabolic dysfunction in Parkinson’s disease
Mark, J. R., & Tansey, M. G. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00827-y · Cited by 25
Wang, H., Cheng, Y., Yeh, T., Liu, H.-F., Weng, Y.-H., Chen, R., Chen, Y., Lu, J., Hwang, T., Wei, K., et al. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115524 · Cited by 18
Zhu, Y., Kohli, N., Young, A. J., Sheldon, M., Coni, J., Rajasekaran, M., Robinson, L., Chroneos, R., Riley, S., Guarnieri, J. W., et al. (2024) · Antioxidants · doi:10.3390/antiox13101226 · Cited by 18
Choi, H., Yoo, H., Lee, J. Y., Park, J., & Jeon, K. (2022) · Biomedicines · doi:10.3390/biomedicines10102386 · Cited by 17
Ju, W., Zhao, S., Li, D., Zhang, J., Xiang, S., & Lian, F. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1546041 · Cited by 16
Wu, H., Han, Y., Liu, J., Zhao, R., Dai, S., Guo, Y., Li, N., Yang, F., & Zeng, S. (2024) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-024-01107-3 · Cited by 16
N-acetylcysteine modulates rotenone-induced mitochondrial Complex I dysfunction in THP-1 cells
Kwok, W. T.-H., Kwak, H. A., & Andreazza, A. C. (2023) · Mitochondrion · doi:10.1016/j.mito.2023.07.001 · Cited by 15
Flores-Gutierrez, C. A., Torres-Sánchez, E. D., Reyes-Uribe, E., Torres-Jasso, J. H., Reyna-Villela, M. Z., Rojas-Bravo, D., & Flores, J. S. (2023) · Brain Sciences · doi:10.3390/brainsci13081194 · Cited by 14
Jia, L., Liao, L., Jiang, Y., Hu, X., Lu, G., Xiao, W., Gong, W., & Jia, X. (2023) · BMC Cancer · doi:10.1186/s12885-023-11519-5 · Cited by 14
Scarcella, M., Scerra, G., Ciampa, M., Caterino, M., Costanzo, M., Rinaldi, L., Feliciello, A., Anzilotti, S., Fiorentino, C., Renna, M., et al. (2024) · iScience · doi:10.1016/j.isci.2024.108959 · Cited by 14
Liu, Y., He, H., Fan, L., Yuan, J., Huang, H., Yang, W., Wang, L., Mo, Z., & Wang, F. (2019) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01712-4 · Cited by 14
Müller, W. E. G., Schröder, H. C., Neufurth, M., & Wang, X. (2021) · Materials Today · doi:10.1016/j.mattod.2021.07.029 · Cited by 15
Terada, K., Murata, A., Toki, E., Goto, S., Yamakawa, H., Setoguchi, S., Watase, D., Koga, M., Takata, J., Matsunaga, K., et al. (2020) · Molecules · doi:10.3390/molecules25184206 · Cited by 13
The Effect of PGC-1alpha-SIRT3 Pathway Activation on Pseudomonas aeruginosa Infection
Maurice, N. M., Bedi, B., Yuan, Z., Lin, K.-C., Goldberg, J. B., Hart, C. M., Bailey, K. L., & Sadikot, R. T. (2022) · Pathogens · doi:10.3390/pathogens11020116 · Cited by 13
Vastegani, S. M., Khoshnam, S. E., Mansouri, E., Ghafouri, S., Bakhtiari, N., Farbood, Y., & Sarkaki, A. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01230-6 · Cited by 13
Abdul, N. S., Nagiah, S., & Chuturgoon, A. A. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.12.008 · Cited by 12
Melatonin Modulates Lipid Metabolism in Porcine Cumulus–Oocyte Complex via Its Receptors
Zhu, T., Guan, S., Lv, D., Zhao, M., Yan, L., Shi, L., Ji, P., Zhang, L., & Liu, G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.648209 · Cited by 12
Magalhães, J. D., Esteves, A. R., Candeias, E., Silva, D. F., Empadinhas, N., & Cardoso, S. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054339 · Cited by 12
Johnson, A. M., Ou, Z.-Y. A., Gordon, R., & Saminathan, H. (2021) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2021.106113 · Cited by 11
Danger-associated metabolic modifications during bacterial infection of macrophages
Dramé, M., Buchrieser, C., & Escoll, P. (2020) · International Immunology · doi:10.1093/intimm/dxaa035 · Cited by 11
Ushiki, T., Mochizuki, T., Suzuki, K., Kamimura, M., Ishiguro, H., Suwabe, T., & Kawase, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911293 · Cited by 10
Hu, H., Zhang, Z., Qian, Y., Yuan, H. S., Ge, W., Huang, S., Zhang, A., Zhang, Y., Jia, Z., & Ding, G. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108948 · Cited by 10
Modeling drug-induced mitochondrial toxicity with human primary cardiomyocytes
Tang, X., Liu, H., Rao, R., Huang, Y., Dong, M., Xu, M., Feng, S., Shi, X., Wang, L., Wang, Z., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2369-3 · Cited by 9
Evaluating the efficacy of vatiquinone in preclinical models of Leigh syndrome and GPX4 deficiency
Kayser, E., Mulholland, M. T., Olkhova, E. A., Chen, Y., Coulson, H., Cairns, O., Truong, V. B., James, K., Johnson, B. M., Hanaford, A. R., et al. (2025) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-025-03582-x · Cited by 12
Akhter, F., Akhter, A., & Zhu, D. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.11.040 · Cited by 8
Yang, P.-N., Chen, W., Lee, J.-W., Lin, C., Chen, Y., Lin, C., Lin, W., Yao, C., Wu, Y., Chang, K., et al. (2023) · Aging · doi:10.18632/aging.204954 · Cited by 7
Vulnerability of Subcellular Structures to Pathogenesis Induced by Rotenone in SH-SY5Y Cells
Pokusa, M., Hajdúchová, D., MENICHOVÁ, V., Evinová, A., Hatoková, Z., & Trancikova, A. K. (2021) · Physiological Research · doi:10.33549/physiolres.934477 · Cited by 7
Metadata
- Authors
- Won, J.-H., Park, S., Hong, S., Son, S., & Yu, J.-W.
- Affiliations
- Yonsei University (KR)
- Corresponding author
- Yu, Je-Wook
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2015-11
- Volume
- 290
- Issue
- 45
- Pages
- 27425-27437
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC4646374
- OpenAlex
- W2269000464
- Cited by
- 142
- References
- 34
- Citations by year
- 2026: 18 · 2025: 16 · 2024: 9 · 2023: 18 · 2022: 12 · 2021: 14 · 2020: 12 · 2019: 15 · 2018: 11 · 2017: 12 · 2016: 5
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
- Funders
- National Research Foundation
- National Research Foundation of Korea (2013R1A2A2A01067985, 2012R1A1A2041532, 2014R1A4A 1008625)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- NLRP3 inflammasome, rotenone, mitochondrial electron transport chain, mitochondrial dysfunction, mitochondrial reactive oxygen species, mitochondrial DNA release, mitochondrial hyperpolarization, mitochondrial depolarization, caspase-1 activation, ASC, bone marrow-derived macrophages, inflammasome activation
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Adenosine Triphosphate, Animals, Carrier Proteins, Cells, Cultured, DNA, Mitochondrial, Electron Transport, Mice, Inbred C57BL, Mitochondria, Rotenone, Uncoupling Agents, Reactive Oxygen Species, Mice, Knockout, Caspase 1, Electron Transport Chain Complex Proteins, Mice, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review